CBS 2019
CBSMD教育中心
中 文

光学相关断层扫描

Abstract

Recommended Article

Pancoronary Plaque Characteristics in STEMI Caused by Culprit Plaque Erosion Versus Rupture: 3-Vessel OCT Study Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromiummetallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial OCT guidance during stent implantation in primary PCI: A randomized multicenter study with nine months of optical coherence tomography follow-up Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study The Relation Between Optical Coherence Tomography-Detected Layered Pattern and Acute Side Branch Occlusion After Provisional Stenting of Coronary Bifurcation Lesions Intravascular optical coherence tomography

Original Research

JOURNAL:CBS2017 Article Link

CBS Insight with Professor Gregg W. Stone

CBS2017 Keywords: CBS Insight; Gregg Stone; Excel trial;



Biography

Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone has served as the national or international principal investigator for more than 50 national and international multicenter randomized trials; has authored more than 1,000 book chapters, manuscripts and abstracts published in peer-reviewed literature, and has delivered thousands of invited lectures around the world. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents; adjunct pharmacology; percutaneous heart valves; new device angioplasty including distal embolic protection, thrombectomy, vascular brachy therapy and stent grafts; intravascular ultrasound imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; clinical trial design; and regulatory issues.


Reference

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease


Remarks


This video is intended for professional use only by physicians and is not intented for reposting or redistribution on other external channels.

Caution: This product is intended for use by or under the direction of a physician. Prior to use, reference CBS2017.

www.cbs2017.org. All rights reserved.